Charles Wohlenberg - Concepedia

Concepedia

Author

Charles Wohlenberg

National Institute of Dental and Craniofacial Research

Also Known As

C R Wohlenberg, C Wohlenberg, C. R. Wohlenberg, C. Wohlenberg, C.R. Wohlenberg, CHARLES WOHLENBERG, Charles R. Wohlenberg, Charles Wohlenberg

24

Publications

1.4K

Citations

18

H-Index

42

Concepts

All Affiliations

National Institute of Dental and Craniofacial Research National Institutes of Health National Institute of Allergy and Infectious Diseases

CW

About

Charles Wohlenberg is an author at National Institute of Dental and Craniofacial Research specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.3K
2	Allergy	3	3	350
3	Cell Biology	2	2	252
4	Clinical Immunology	1	1	31
5	Endocrinology	1	1	29

Charles Wohlenberg

×

18

Publications

1.4K

Citations

18

H-Index

	Year	Citations
Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in Mice Kenneth J. Cremer, Michael Mackett, Charles Wohlenberg, Science VaccinationMolecular VirologyVaccine DevelopmentSynthetic VirologyNeurovirology	1985	203
Herpes simplex virus DNA sequences in the CNS of latently infected mice Carlos V. Cabrera, Charles Wohlenberg, Harry Openshaw, Nature Molecular VirologyViral PersistenceNeurovirologyPathogenesisViral Pathogenesis	1980	182
Prevention of ultraviolet-light-induced herpes labialis by sunscreen James F. Rooney, Margaret L. Mannix, Charles Wohlenberg, The Lancet Ultraviolet LightPhototoxicityUltraviolet-light-induced HerpesWound HealingDermatology	1991	147
Acute and Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Immune Control and Virus Reactivation Harry Openshaw, Ludmila V. Asher, Charles Wohlenberg, Journal of General Virology Veterinary VaccineGanglionic InfectionLatent InfectionViral PathogenesisImmunology	1979	140
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination James F. Rooney, Charles Wohlenberg, Kenneth J. Cremer, Journal of Virology ImmunologyGlycoprotein DImmunotherapyVaccinia Virus VectorVaccine Target	1988	130
Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Efficacy of Immunization Richard W. Price, M. Antoinette Walz, Charles Wohlenberg, Science Veterinary VaccineLatent InfectionImmunologyViral PathogenesisActive Immunization	1975	101
Latency of Herpes Simplex Virus in Absence of Neutralizing Antibody: Model for Reactivation Tsuyoshi Sekizawa, Harry Openshaw, Charles Wohlenberg, Science VaccinationNeutralizing AntibodyType 1Latent VirusViral Persistence	1980	84
Inhibition or Enhancement of Immunological Injury of Virus-Infected Cells Arnold M. Brier, Charles Wohlenberg, Joel D. Rosenthal, Proceedings of the National Academy of Sciences VaccinationVirus-infected CellsAllergyViral PersistenceViral Pathogenesis	1971	80
Cutaneous Disorders and Viral Gene Expression in HIV-1 Transgenic Mice Jeffrey B. Kopp, James F. Rooney, Charles Wohlenberg, AIDS Research and Human Retroviruses ImmunologyPathologyDermatologyTransgenic MiceImmunotherapy	1993	49
Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen Charles Flexner, Brian R. Murphy, James F. Rooney, Nature VaccinationVaccinologyVaccine DevelopmentMedicineVaccine Target	1988	43

Page 1